journal article·2023-09-26Open access

Exploring the Landscape of the PP7 Virus-like Particle for Peptide Display

Parisa Keshavarz-Joud, Liangjun Zhao, Daija Bobe, Carolina Hernandez, Mykhailo Kopylov, Laura Y. Yen, Naima Djeddar, Brianna Thompson, Caleb Connors, Greg Gibson, Anton Bryksin, M.G. Finn

ACS Nano· Volume 17· Issue 18

Abstract

Self-assembling virus-like particles (VLPs) can tolerate a wide degree of genetic and chemical manipulation to their capsid protein to display a foreign molecule polyvalently. We previously reported the successful incorporation of foreign peptide sequences in the junction loop and onto the C-terminus of PP7 dimer VLPs, as these regions are accessible for surface display on assembled capsids. Here, we report the implementation of a library-based approach to test the assembly tolerance of PP7 dimer capsid proteins to insertions or terminal extensions of randomized 15-mer peptide sequences. By performing two iterative rounds of assembly-based selection, we evaluated the degree of favorability of all 20 amino acids at each of the 15 randomized positions. Deep sequencing analysis revealed a distinct preference for the inclusion of hydrophilic peptides and negatively charged amino acids (Asp and Glu) and the exclusion of positively charged peptides and bulky and hydrophobic amino acid residues (Trp, Phe, Tyr, and Cys). Within the libraries tested here, we identified 4000 to 22,000 unique 15-mer peptide sequences that can successfully be displayed on the surface of the PP7 dimer capsid. Overall, the use of small initial libraries consisting of no more than a few million members yielded a significantly larger number of unique and assembly-competent VLP sequences than have been previously characterized for this class of nucleoprotein particle.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Bacteriophages and microbial interactions · Monoclonal and Polyclonal Antibodies Research · Virology and Viral Diseases

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, Georgia 30306, United States

New York Structural Biology Center, New York, New York 10027, United States

Parker H. Petit Institute for Bioengineering and Biosciences, Georgia Institute of Technology, Atlanta, Georgia 30306, United States

School of Biological Sciences, Georgia Institute of Technology, Atlanta, Georgia 30306, United States

Funding

Centers for Disease Control and Prevention · National Institute of Allergy and Infectious Diseases · Defense Threat Reduction Agency · Simons Foundation

References (41)

Show source-provided references
1. Stockley P. G. · 2008 · 2110.1016/B978-012374410-4.00760-3 ↗
2. 10.1016/0042-6822(70)90138-810.1016/0042-6822(70)90138-8 ↗
3. 10.1021/ja076536310.1021/ja0765363 ↗
4. 10.1159/00015046910.1159/000150469 ↗
5. 10.1371/journal.pone.000254710.1371/journal.pone.0002547 ↗
6. 10.1186/1477-3155-5-1010.1186/1477-3155-5-10 ↗
7. 10.1016/j.vaccine.2010.04.04910.1016/j.vaccine.2010.04.049 ↗
8. 10.1002/1521-4095(20020318)14:6<415::AID-ADMA415>3.0.CO;2-W10.1002/1521-4095(20020318)14:6<415::AID-ADMA415>3.0.CO;2-W ↗
9. 10.1038/nnano.2007.29910.1038/nnano.2007.299 ↗
10. 10.1002/anie.20100524310.1002/anie.201005243 ↗
11. 10.1038/nchem.144210.1038/nchem.1442 ↗
12. 10.1021/ja211011k10.1021/ja211011k ↗
13. 10.1021/acsbiomaterials.6b0053210.1021/acsbiomaterials.6b00532 ↗
14. 10.1007/978-3-540-69379-6_110.1007/978-3-540-69379-6_1 ↗
15. 10.1038/srep1923410.1038/srep19234 ↗
16. 10.1021/acs.bioconjchem.8b0045810.1021/acs.bioconjchem.8b00458 ↗
17. 10.1161/CIRCRESAHA.111.24937510.1161/CIRCRESAHA.111.249375 ↗
18. 10.1002/anie.20120361210.1002/anie.201203612 ↗
19. 10.1021/acs.bioconjchem.5b0048510.1021/acs.bioconjchem.5b00485 ↗
20. 10.1021/bi901306p10.1021/bi901306p ↗
21. 10.1021/bm300590x10.1021/bm300590x ↗
22. 10.1021/acsnano.8b0968310.1021/acsnano.8b09683 ↗
23. 10.1016/j.jmb.2008.04.04910.1016/j.jmb.2008.04.049 ↗
24. 10.1038/s41467-018-03783-y10.1038/s41467-018-03783-y ↗
25. 10.1021/jacs.8b1073410.1021/jacs.8b10734 ↗
26. 10.1021/acs.biomac.0c0098710.1021/acs.biomac.0c00987 ↗
27. 10.1016/j.virol.2023.01.00110.1016/j.virol.2023.01.001 ↗
28. 10.1016/j.jmb.2006.08.05310.1016/j.jmb.2006.08.053 ↗
29. 10.1074/jbc.M10241120010.1074/jbc.M102411200 ↗
30. 10.1093/nar/gkf55210.1093/nar/gkf552 ↗
31. 10.1016/j.jmb.2007.03.02010.1016/j.jmb.2007.03.020 ↗
32. 10.1006/viro.2000.037310.1006/viro.2000.0373 ↗
33. 10.1016/j.jmb.2006.08.05310.1016/j.jmb.2006.08.053 ↗
34. 10.1016/0022-2836(82)90515-010.1016/0022-2836(82)90515-0 ↗
35. 10.3390/v1402022510.3390/v14020225 ↗
36. 10.1126/science.aaf881810.1126/science.aaf8818 ↗
37. 10.1038/nature1801010.1038/nature18010 ↗
38. 10.1002/pro.380210.1002/pro.3802 ↗
39. 10.1038/nature2515710.1038/nature25157 ↗
40. 10.1186/1477-3155-9-2210.1186/1477-3155-9-22 ↗
41. 10.1073/pnas.180052711510.1073/pnas.1800527115 ↗